| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/10/2011 | US20110034436 spirocyclic aminoquinolnes as gsk-3 inhibitors |
| 02/10/2011 | US20110034433 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/10/2011 | US20110034432 Benzamide derivatives and their use as glucokinase activating agents |
| 02/10/2011 | US20110031485 Organic light emitting device |
| 02/10/2011 | US20110031484 Condensed-cyclic compound and organic light emitting diode having organic layer including the same |
| 02/10/2011 | CA2770471A1 Processes for the preparation of vardenafil |
| 02/10/2011 | CA2770248A1 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators |
| 02/10/2011 | CA2770155A1 Novel azaheterocyclic compounds |
| 02/10/2011 | CA2769245A1 Mesoionic pesticides |
| 02/10/2011 | CA2768043A1 Cyclopropyl modulators of p2y12 receptor |
| 02/10/2011 | CA2763956A1 Metabotropic glutamate receptor modulators |
| 02/09/2011 | EP2281819A1 Benzimidazolyl or benzoxazolyl derivatives |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2280981A1 Bridged heterocycles as hiv integrase inhibitors |
| 02/09/2011 | EP2280978A1 Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors |
| 02/09/2011 | EP2280977A1 Method for producing bicyclic guanidines by use of a cyclic thiourea |
| 02/09/2011 | EP2280976A1 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines as gsk3beta-inhibitors |
| 02/09/2011 | EP2280975A1 7h-indoloý2,1-a¨ý2¨benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c |
| 02/09/2011 | EP2280974A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| 02/09/2011 | EP2280973A1 Carba-nucleoside analogs for antiviral treatment |
| 02/09/2011 | EP2280970A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 02/09/2011 | EP2280943A1 New substituted spiroýcycloalkyl-1,3'-indol¨-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors. |
| 02/09/2011 | EP2280706A1 Lipoprotein lipase-activating compositions comprising benzene derivates |
| 02/09/2011 | EP1575955B1 Pyrrolobenzodiazepines for the treatment of proliferative diseases |
| 02/09/2011 | EP1451192B1 Novel crystalline compound |
| 02/09/2011 | CN101970443A Rna-selective hybridization reagent and utilization of the same |
| 02/09/2011 | CN101970442A Bicyclic pyrrole compound |
| 02/09/2011 | CN101970441A Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 02/09/2011 | CN101970440A 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| 02/09/2011 | CN101970435A Pyrrolopyrimidines and pyrrolopyridines |
| 02/09/2011 | CN101970433A Gamma secretase modulators |
| 02/09/2011 | CN101970426A Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer |
| 02/09/2011 | CN101970415A 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101970396A New ruthenium complexes as catalysts for metathesis reactions |
| 02/09/2011 | CN101967149A Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of nitryl and preparation and application |
| 02/09/2011 | CN101967148A Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of p-benzenesulfonyloxy and preparation and application |
| 02/09/2011 | CN101967143A Ligands for G-protein coupled receptors |
| 02/09/2011 | CN101384595B Salt of CD 80 antagonist |
| 02/08/2011 | US7884125 7-benzyl-7-azabicyclo[2.2.1]hept-1-ylmethyl)-pyridin-2-yl-amine, used for the treatment of diseases mediated by Nicotinic Acetylcholine Receptors, such as pain, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy and drug addiction |
| 02/08/2011 | US7884124 Fluoro-substituted inhibitors of D-amino acid oxidase |
| 02/08/2011 | US7884123 3-(1H-indol-2-yl)-1H-thieno[2,3-c]pyrazole-5-(N-phenoxycarboxamide); anticancer agents; protein kinase inhibitors |
| 02/08/2011 | US7884110 4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)-pyridin-3-yl]-3-trifluoromethyl-benzenesulfonamide sodium salt; for chemokine-mediated conditions or diseases including certain inflammatory and immunoregulatory disorders; restenosis, multiple sclerosis, arthritis |
| 02/08/2011 | US7884104 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | CA2610888C Inhibitors of akt activity |
| 02/08/2011 | CA2605899C Triazole derivatives as vasopressin antagonists |
| 02/08/2011 | CA2553785C Compounds and compositions as protein kinase inhibitors |
| 02/08/2011 | CA2459374C Photoactivable nitrogen bases |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2374279C Process for the preparation of herbicidal derivatives |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/08/2011 | CA2223407C Oxidant scavengers |
| 02/03/2011 | WO2011014817A1 Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors |
| 02/03/2011 | WO2011014520A2 Compounds and compositions as modulators of gpr119 activity |
| 02/03/2011 | WO2011014190A1 Phthalocyanines and naphthalocyanines with near-ir absorptions for inkjet inks |
| 02/03/2011 | WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/03/2011 | WO2011013992A2 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 02/03/2011 | WO2011013729A1 Fused imidazole derivative having ttk inhibitory action |
| 02/03/2011 | WO2011013656A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | WO2011013597A1 Fullerene derivatives |
| 02/03/2011 | WO2011012698A2 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 02/03/2011 | WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders |
| 02/03/2011 | WO2011012540A1 Tricyclic inhibitors of jak |
| 02/03/2011 | WO2011012538A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 02/03/2011 | WO2011012534A1 Plk inhibitor salts |
| 02/03/2011 | WO2010124042A3 Modulators of 5-ht receptors and methods of use thereof |
| 02/03/2011 | WO2010092090A3 Novel salts of sitagliptin |
| 02/03/2011 | US20110028730 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands |
| 02/03/2011 | US20110028712 Diamine salts of carboxylic acids |
| 02/03/2011 | US20110028512 Bis-heterocyclic imidazolyl compounds |
| 02/03/2011 | US20110028487 Imidazopyrimidines and uses thereof |
| 02/03/2011 | US20110028483 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 02/03/2011 | US20110028476 Proton pump inhibitors |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028450 Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028337 Nucleobase characterisation |
| 02/03/2011 | US20110028310 Catalysts and methods for catalytic oxidation |
| 02/03/2011 | US20110026117 Lyotropic liquid crystal systems based on bisacenaphthopyrazinoquinoxaline derivatives and methods of making |
| 02/03/2011 | CA2769209A1 Pyrrolo [1,2-b] pyridazine derivatives as janus kinase inhibitors |
| 02/03/2011 | CA2769161A1 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 02/03/2011 | CA2768821A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | CA2768290A1 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/03/2011 | CA2766535A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 02/03/2011 | CA2763628A1 Tricyclic inhibitors of jak |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279737A1 Heterocyclic compounds that are active as beta lactamase inhibitors |
| 02/02/2011 | EP2279186A1 CONVERSION OF TRYPTOPHAN INTO ß-CARBOLINE DERIVATIVES |
| 02/02/2011 | EP2278977A1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors |
| 02/02/2011 | EP2278973A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
| 02/02/2011 | EP2032577B1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 02/02/2011 | EP1664092B1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 02/02/2011 | EP1364212B1 Three hybrid assay system |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | CN1878845B Allergen decomposer and antiallergenic feather |
| 02/02/2011 | CN101965350A Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti-cancer agents |